Insider Transactions in Q3 2021 at Rx Sight, Inc. (RXST)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 05
2021
|
Ilya Goldshleger |
BUY
Open market or private purchase
|
Indirect |
1,372
+50.0%
|
$17,836
$13.69 P/Share
|
|
Aug 05
2021
|
Ilya Goldshleger |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$14,000
$14.49 P/Share
|
|
Aug 05
2021
|
Eric Weinberg |
BUY
Open market or private purchase
|
Indirect |
9
+0.96%
|
$126
$14.9 P/Share
|
|
Aug 05
2021
|
Ronald M Md Kurtz President & CEO |
BUY
Open market or private purchase
|
Indirect |
3,638
+0.45%
|
$47,294
$13.85 P/Share
|
|
Aug 04
2021
|
Eric Weinberg |
BUY
Open market or private purchase
|
Indirect |
615
+40.17%
|
$9,840
$16.25 P/Share
|
|
Aug 03
2021
|
Eric Weinberg |
BUY
Open market or private purchase
|
Indirect |
1
+0.33%
|
$17
$17.03 P/Share
|
|
Aug 03
2021
|
Robert Keith Warner |
BUY
Open market or private purchase
|
Indirect |
43,750
+43.37%
|
$700,000
$16.0 P/Share
|
|
Aug 03
2021
|
Robert Keith Warner |
BUY
Grant, award, or other acquisition
|
Direct |
13,378
+43.18%
|
-
|
|
Aug 03
2021
|
Robert J Palmisano |
BUY
Grant, award, or other acquisition
|
Direct |
13,378
+43.18%
|
-
|
|
Aug 03
2021
|
Julie Andrews |
BUY
Open market or private purchase
|
Direct |
15,625
+35.01%
|
$250,000
$16.0 P/Share
|
|
Aug 03
2021
|
Julie Andrews |
BUY
Grant, award, or other acquisition
|
Direct |
13,378
+43.18%
|
-
|
|
Aug 03
2021
|
Ronald M Md Kurtz President & CEO |
BUY
Open market or private purchase
|
Direct |
125,000
+50.0%
|
$2,000,000
$16.0 P/Share
|
|
Aug 03
2021
|
Eric Weinberg |
BUY
Open market or private purchase
|
Direct |
31,250
+50.0%
|
$500,000
$16.0 P/Share
|
|
Aug 03
2021
|
William J Phd Link |
BUY
Open market or private purchase
|
Direct |
31,250
+45.71%
|
$500,000
$16.0 P/Share
|
|
Aug 03
2021
|
William J Phd Link |
BUY
Conversion of derivative security
|
Indirect |
2,016,778
+50.0%
|
-
|
|
Aug 03
2021
|
Jesse Anderson Corley |
BUY
Open market or private purchase
|
Indirect |
78,125
+15.19%
|
$1,250,000
$16.0 P/Share
|
|
Aug 03
2021
|
Bakker Juliet Tammenoms |
BUY
Open market or private purchase
|
Indirect |
625,000
+27.96%
|
$10,000,000
$16.0 P/Share
|
|
Aug 03
2021
|
Bakker Juliet Tammenoms |
BUY
Conversion of derivative security
|
Indirect |
1,863,613
+50.0%
|
-
|
|
Aug 03
2021
|
Bakker Juliet Tammenoms |
BUY
Open market or private purchase
|
Direct |
12,500
+40.51%
|
$200,000
$16.0 P/Share
|
|
Aug 03
2021
|
Bruce C Robertson Director |
BUY
Conversion of derivative security
|
Indirect |
1,385,037
+50.0%
|
-
|
|
Aug 03
2021
|
Daniel Mark Schwartz Director |
BUY
Conversion of derivative security
|
Direct |
3,969
+0.96%
|
-
|
|
Aug 03
2021
|
Richard M. Wolfen Director |
BUY
Conversion of derivative security
|
Indirect |
1,489,805
+45.81%
|
-
|
|
Aug 03
2021
|
Richard M. Wolfen Director |
BUY
Conversion of derivative security
|
Direct |
76,974
+49.61%
|
-
|
|
Aug 03
2021
|
Rx Sight I, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,016,778
+50.0%
|
-
|
|
Aug 02
2021
|
Eric Weinberg |
BUY
Open market or private purchase
|
Indirect |
90
+23.08%
|
$1,530
$17.04 P/Share
|
|
Jul 30
2021
|
Eric Weinberg |
BUY
Open market or private purchase
|
Indirect |
210
+50.0%
|
$3,360
$16.94 P/Share
|
|
Jul 30
2021
|
Jesse Anderson Corley |
BUY
Grant, award, or other acquisition
|
Direct |
5,859
+50.0%
|
-
|
|
Jul 30
2021
|
William J Phd Link |
BUY
Grant, award, or other acquisition
|
Direct |
5,859
+50.0%
|
-
|
|
Jul 30
2021
|
Bakker Juliet Tammenoms |
BUY
Grant, award, or other acquisition
|
Direct |
5,859
+50.0%
|
-
|